Drugmaker Actavis’ shares up

Published



Shares of Actavis Inc. rose Thursday after reports surfaced that one of the world’s biggest generic drugmaker has drawn interest from some competitors considering an acquisition.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.